Increasing Newborn Screening Laboratory Capability to Detect Severe Combined Immunodeficiency (SCID) Using Next Generation Sequencing Technologies

Funding Opportunity ID: 292910 Opportunity Number: CDC-RFA-EH17-1703 Opportunity Title: Increasing Newborn Screening Laboratory Capability to Detect Severe Combined Immunodeficiency (SCID) Using Next Generation Sequencing TechnologiesOpportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.065Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Additional Information on Eligibility: The authorizing statute allows awards to States, political subdivisions, and other public and nonprofit private entities. Further, awardees must represent or be an administrative partner to an established state or territorial newborn screening program that currently screens for SCID in a U.S. state or territory. Applicants should provide a letter certifying they represent or are an administrative partner to an established state or territorial newborn screening program.Agency Code: HHS-CDC-NCEHAgency Name: Department of Health and Human ServicesCenters for Disease Control - NCEHPosted Date: Mar 31, 2017Close Date: May 31, 2017 Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.Last Updated Date: Mar 31, 2017Award Ceiling: $150,000Award Floor: $150,000Estimat...
Source: Grants.gov - Category: Research Tags: Health Source Type: funding